Millendo Therapeutics (NASDAQ:MLND) Upgraded at Zacks Investment Research – Riverton Roll
Millendo Therapeutics (NASDAQ:MLND) Upgraded at Zacks Investment Research Riverton Roll
Millendo Therapeutics (NASDAQ:MLND) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to …
Source: Investment New Feed